Saba Capital Management’s The Oncology Institute Warrant TOIIW Stock Holding History
Bought
Maintained
Sold
Other funds holding TOIIW
SRCM
MF
ECM
GCL
BI
MS
MCM
Saba Capital Management's TOIIW Position: Q4 2020 in Review
Saba Capital Management sold out of The Oncology Institute Warrant (TOIIW) in Q4 2020, closing a stake of 24,464 shares — an estimated $52K sold.
Saba Capital Management first reported a position in TOIIW in Q3 2020 and held it in 1 quarter. The position peaked at $52K in Q3 2020. 25 funds tracked by Wall St. Rank hold TOIIW as of Q4 2020.
- Saba Capital Management reported no remaining The Oncology Institute Warrant position as of Q4 2020 after selling out during the quarter.
- Saba Capital Management sold 24,464 The Oncology Institute Warrant shares in Q4 2020, an estimated $52K.
- Saba Capital Management first reported a position in The Oncology Institute Warrant in Q3 2020 and held it in 1 quarter.
- Saba Capital Management's The Oncology Institute Warrant position peaked at $52K in Q3 2020.
- 25 funds tracked by Wall St. Rank held The Oncology Institute Warrant as of Q4 2020.
Based on Saba Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.